Yat Wai Wong
Chief Executive Officer chez JBM (HEALTHCARE) LIMITED
Fortune : 75 360 $ au 31/03/2024
Profil
Yat Wai Wong is currently the Chief Executive Officer & Executive Officer at JBM (Healthcare) Ltd.
Prior to this, he held positions as an Executive Director at Daewoong Pharmaceutical Co., Ltd.
from 2014 to 2017, Marketing Director-China & Japan at Coloplast (Hong Kong) Ltd.
from 2009 to 2013, Marketing Manager-OTC Generic Department at Mekim Ltd.
from 1993 to 1995, Marketing Manager-Hong Kong at Ferring Pharmaceuticals Ltd.
from 1996 to 2003, and VP-Medical & Science Affairs at KCI Hong Kong Holding Ltd.
in 2014.
Mr. Wong graduated from the University of Hong Kong in 2000 and The Hong Kong Polytechnic University in 1987.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
JBM (HEALTHCARE) LTD.
0,07% | 24/04/2024 | 620 862 ( 0,07% ) | 75 360 $ | 31/03/2024 |
Postes actifs de Yat Wai Wong
| Sociétés | Poste | Début |
|---|---|---|
| JBM (HEALTHCARE) LIMITED | Chief Executive Officer | 22/09/2020 |
Anciens postes connus de Yat Wai Wong
| Sociétés | Poste | Fin |
|---|---|---|
| DAEWOONG PHARMACEUTICAL CO., LTD | Director/Board Member | 01/07/2017 |
| KCI Hong Kong Holding Ltd. | Corporate Officer/Principal | 01/08/2014 |
Coloplast (Hong Kong) Ltd.
 Coloplast (Hong Kong) Ltd. Medical SpecialtiesHealth Technology Part of Coloplast A/S, Coloplast (Hong Kong) Ltd. is a Chinese company that develops products and services to improve the lives of people with personal medical conditions. The private company is based in Hong Kong, Hong Kong. The company works closely with their customers to create personalized solutions to meet their unique needs. | Corporate Officer/Principal | 01/09/2013 |
Ferring Pharmaceuticals Ltd.
 Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Sales & Marketing | 01/09/2003 |
| Mekim Ltd. | Sales & Marketing | 01/04/1995 |
Formation de Yat Wai Wong
| University of Hong Kong | Graduate Degree |
| The Hong Kong Polytechnic University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| DAEWOONG PHARMACEUTICAL CO., LTD | Health Technology |
| JBM (HEALTHCARE) LIMITED | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Mekim Ltd. | |
Ferring Pharmaceuticals Ltd.
Ferring Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals Ltd. manufactures and produces pharmaceutical products. It offers Zomacton (somatropin) for that treatment of growth failure in children and for girl’s diagnosed with Turners syndrome; GONAPEPTYL (triptorelin), a GnRH agonist that is used for the treatment of children with central precocious puberty; Testim (testosterone gel), a hydroalcoholic topical gel; and PENTASA (mesalazine), which is used for the treatment of inflammatory bowel diseases. The company was founded in 1975 and is headquartered in Middlesex, the United Kingdom. | Health Technology |
Coloplast (Hong Kong) Ltd.
Coloplast (Hong Kong) Ltd. Medical SpecialtiesHealth Technology Part of Coloplast A/S, Coloplast (Hong Kong) Ltd. is a Chinese company that develops products and services to improve the lives of people with personal medical conditions. The private company is based in Hong Kong, Hong Kong. The company works closely with their customers to create personalized solutions to meet their unique needs. | Health Technology |
| KCI Hong Kong Holding Ltd. |
